HealthTronics Proposes Endocare Acquisition
HealthTronics has made an unsolicited bid to buy Endocare for $26.9 million in cash. The offer represents a 20% premium over Endocare’s closing stock price […]
Month: August 2008
[Video] Interview with Timothy Surgenor, President & CEO of Cyberkinetics Neurotechnology
Cyberkinetics Neurotechnology, at one time an oft-discussed early stage device firm, has seen a steady decline in share price. Current market conditions are largely to […]
Arbios Systems Runs Out of Steam
Arbios Systems has suspended operations and laid-off employees while it focuses on raising additional funds. If the company fails to secure financing by the end […]
Clarient Q2 Revenues Up 71%
Not wanting to break a winning streak, Clarient delivered its 16th consecutive quarter of quarterly revenue growth. The company posted revenues of $16.9 million in […]
NeuroMetrix: Revenues Decline, NC-Stat Prospects Bleak
NeuroMetrix reported quarterly revenues of $8.5 million yesterday, down approximately 26% from the same period in 2007. The company generated a scant $510,000 (or 6% […]
Chembio Q2 Results: Record Revenues, Net Loss Decreases
Chembio Diagnostics reported second quarter revenues of $2.72 million, an 8.6% increase over Q2 2007 and higher than any previous quarter. The lion’s share of […]
[Video] On Greatbatch, Stereotaxis: Interview with Keay Nakae, Analyst at Collins Stewart
In this video, Keay discusses Greatbatch, which he believes is a compelling buy based on its current valuation. Keay also discusses Stereotaxis. The company has […]
[Video] Medical Device Market Overview: Interview with Keay Nakae, Analyst at Collins Stewart
Some insightful commentary care of Keay Nakae, the medical device analyst at Collins Stewart. We spoke to Keay earlier this month at the firm’s annual […]
Electro-Optical Sciences Nears Pivotal Trial Completion
Electro-Optical Sciences (EOS), developer of The MelaFind System, a hand held imaging device that detects melanomas at an early stage, has completed patient accrual in […]
Langer Cuts the Fat: Sells Bi-Op Subsidiary for Less than 2003 Purchase Price
Langer, Inc. has completed the sale of Bi-Op Laboratories for $2,125,000 in cash. Buyers include a group of investors and Raynald Henry, the current Bi-Op […]